data_2m8f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.48 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 13' ' ' GLY . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 11' ' ' VAL . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' VAL . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' ASP . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.405 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.537 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG21 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.49 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 11' ' ' VAL . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 9' ' ' ASP . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.41 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' VAL . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ASP . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.41 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' VAL . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 9' ' ' ASP . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 11' ' ' VAL . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 9' ' ' ASP . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.513 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.513 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt -136.52 1.91 2.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.23 -12.76 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.37 1.868 . . . . 0.0 114.89 -160.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 C--O 1.255 1.373 0 CA-C-O 116.803 -1.57 . . . . 0.0 108.639 122.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.51 175.58 13.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.28 1.86 0.27 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 130.862 3.665 . . . . 0.0 106.029 179.379 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -172.11 -157.14 0.11 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.27 -72.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.202 1.001 . . . . 0.0 108.694 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 128.791 2.837 . . . . 0.0 111.725 152.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.04 9.69 3.54 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -173.38 9.88 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 130.185 3.394 . . . . 0.0 112.066 -160.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t0 . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 131.098 3.759 . . . . 0.0 108.164 -170.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.61 172.34 13.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.77 -0.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.571 1.548 . . . . 0.0 113.556 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.751 4.42 . . . . 0.0 105.342 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -136.65 19.96 3.09 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.97 23.28 0.21 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 128.666 2.786 . . . . 0.0 111.476 -163.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 . . . . . 0 C--O 1.259 1.57 0 C-N-CA 130.004 3.322 . . . . 0.0 108.711 178.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.48 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 13' ' ' GLY . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 11' ' ' VAL . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp -144.59 170.02 16.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.86 -0.8 0.51 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 C--O 1.248 1.011 1 C-N-CA 132.201 4.2 . . . . 0.0 105.465 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' VAL . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' ASP . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 176.17 13.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.3 1.26 0.32 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.746 3.619 . . . . 0.0 106.222 177.595 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.2 177.7 8.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -144.41 -42.75 0.25 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.349 0.66 . . . . 0.0 111.747 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 112.107 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.537 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.37 173.79 13.61 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.03 -1.72 0.35 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.179 1.391 . . . . 0.0 113.867 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.253 4.221 . . . . 0.0 105.275 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG21 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.49 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.13 172.83 15.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.78 -22.1 0.72 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.793 1.637 . . . . 0.0 112.457 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 130.526 3.531 . . . . 0.0 108.696 171.029 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 11' ' ' VAL . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 9' ' ' ASP . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.27 175.33 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.91 -2.66 0.29 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 130.889 3.676 . . . . 0.0 106.583 -178.279 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp -154.41 -178.34 7.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.56 -2.83 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.26 1.633 0 C-N-CA 131.13 3.772 . . . . 0.0 105.708 178.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.07 -177.32 5.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.47 -59.34 0.27 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.418 1.487 . . . . 0.0 109.15 170.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.752 2.421 . . . . 0.0 111.909 157.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.66 -176.13 5.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.21 -70.99 0.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.422 1.089 . . . . 0.0 109.69 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.143 0 O-C-N 124.877 1.361 . . . . 0.0 110.31 141.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.26 173.55 14.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.64 -1.81 0.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.206 1.402 . . . . 0.0 114.024 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.261 1.676 1 C-N-CA 132.232 4.213 . . . . 0.0 105.515 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' VAL . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' ASP . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -160.06 -171.54 3.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.35 -4.61 0.6 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--O 1.249 1.056 1 C-N-CA 131.872 4.069 . . . . 0.0 104.784 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' VAL . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 9' ' ' ASP . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -154.5 176.02 12.88 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.89 -3.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.904 1.282 . . . . 0.0 114.247 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 C-N-CA 131.365 3.866 . . . . 0.0 106.296 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 11' ' ' VAL . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 9' ' ' ASP . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp -158.85 173.47 16.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.21 -1.63 0.28 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 130.273 3.429 . . . . 0.0 106.329 177.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.513 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.513 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -151.71 173.22 14.96 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.67 -2.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.194 1.398 . . . . 0.0 114.007 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.249 1.043 1 C-N-CA 131.885 4.074 . . . . 0.0 105.207 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 5' ' ' MET . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.524 HG23 ' HD2' ' A' ' 4' ' ' PRO . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD2' HG23 ' A' ' 3' ' ' THR . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.435 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 3' ' ' THR . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' THR . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 4' ' ' PRO . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 3' ' ' THR . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.439 ' HB3' HG22 ' A' ' 3' ' ' THR . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.43 ' H ' HG22 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.434 HG23 ' HD2' ' A' ' 4' ' ' PRO . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 3' ' ' THR . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' A' ' 3' ' ' THR . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt -136.52 1.91 2.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.23 -12.76 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.37 1.868 . . . . 0.0 114.89 -160.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 C--O 1.255 1.373 0 CA-C-O 116.803 -1.57 . . . . 0.0 108.639 122.132 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 5' ' ' MET . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.51 175.58 13.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.28 1.86 0.27 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 130.862 3.665 . . . . 0.0 106.029 179.379 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.524 HG23 ' HD2' ' A' ' 4' ' ' PRO . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD2' HG23 ' A' ' 3' ' ' THR . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -172.11 -157.14 0.11 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.27 -72.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.202 1.001 . . . . 0.0 108.694 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 128.791 2.837 . . . . 0.0 111.725 152.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.435 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 3' ' ' THR . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.04 9.69 3.54 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -173.38 9.88 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 130.185 3.394 . . . . 0.0 112.066 -160.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t0 . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 131.098 3.759 . . . . 0.0 108.164 -170.895 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' THR . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.61 172.34 13.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.77 -0.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.571 1.548 . . . . 0.0 113.556 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.751 4.42 . . . . 0.0 105.342 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.423 ' HE1' ' HB1' ' A' ' 23' ' ' ALA . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -136.65 19.96 3.09 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' HB1' ' HE1' ' A' ' 16' ' ' TRP . . . -158.97 23.28 0.21 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 128.666 2.786 . . . . 0.0 111.476 -163.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 19' ' ' HIS . 60.9 m-20 . . . . . 0 C--O 1.259 1.57 0 C-N-CA 130.004 3.322 . . . . 0.0 108.711 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 4' ' ' PRO . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 3' ' ' THR . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp -144.59 170.02 16.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.86 -0.8 0.51 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 C--O 1.248 1.011 1 C-N-CA 132.201 4.2 . . . . 0.0 105.465 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.439 ' HB3' HG22 ' A' ' 3' ' ' THR . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 176.17 13.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.3 1.26 0.32 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.746 3.619 . . . . 0.0 106.222 177.595 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.2 177.7 8.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -144.41 -42.75 0.25 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.349 0.66 . . . . 0.0 111.747 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 112.107 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.37 173.79 13.61 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.03 -1.72 0.35 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.179 1.391 . . . . 0.0 113.867 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.253 4.221 . . . . 0.0 105.275 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.43 ' H ' HG22 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.13 172.83 15.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.78 -22.1 0.72 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.793 1.637 . . . . 0.0 112.457 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 130.526 3.531 . . . . 0.0 108.696 171.029 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.27 175.33 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.91 -2.66 0.29 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 130.889 3.676 . . . . 0.0 106.583 -178.279 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp -154.41 -178.34 7.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.56 -2.83 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.26 1.633 0 C-N-CA 131.13 3.772 . . . . 0.0 105.708 178.915 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.434 HG23 ' HD2' ' A' ' 4' ' ' PRO . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 3' ' ' THR . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' A' ' 3' ' ' THR . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.07 -177.32 5.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.47 -59.34 0.27 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.418 1.487 . . . . 0.0 109.15 170.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.752 2.421 . . . . 0.0 111.909 157.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.66 -176.13 5.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.21 -70.99 0.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.422 1.089 . . . . 0.0 109.69 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.143 0 O-C-N 124.877 1.361 . . . . 0.0 110.31 141.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.26 173.55 14.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.64 -1.81 0.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.206 1.402 . . . . 0.0 114.024 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.261 1.676 1 C-N-CA 132.232 4.213 . . . . 0.0 105.515 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -160.06 -171.54 3.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.35 -4.61 0.6 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--O 1.249 1.056 1 C-N-CA 131.872 4.069 . . . . 0.0 104.784 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -154.5 176.02 12.88 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.89 -3.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.904 1.282 . . . . 0.0 114.247 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 C-N-CA 131.365 3.866 . . . . 0.0 106.296 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp -158.85 173.47 16.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.21 -1.63 0.28 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 130.273 3.429 . . . . 0.0 106.329 177.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -151.71 173.22 14.96 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.67 -2.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.194 1.398 . . . . 0.0 114.007 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.249 1.043 1 C-N-CA 131.885 4.074 . . . . 0.0 105.207 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 5' ' ' MET . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.524 HG23 ' HD2' ' A' ' 4' ' ' PRO . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD2' HG23 ' A' ' 3' ' ' THR . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.435 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 3' ' ' THR . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' THR . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 4' ' ' PRO . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 3' ' ' THR . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.439 ' HB3' HG22 ' A' ' 3' ' ' THR . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.55 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.55 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.43 ' H ' HG22 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.484 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 15' ' ' TYR . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 3' ' ' THR . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' A' ' 3' ' ' THR . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HA ' HE21 ' A' ' 14' ' ' GLN . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.546 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.376 0 N-CA-C 113.913 0.325 . . . . 0.0 113.913 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.93 -17.99 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.869 3.046 . . . . 0.0 116.62 -160.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 152.84 95.07 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.247 1.819 . . . . 0.0 112.792 -174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.22 65.86 7.76 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 124.334 3.356 . . . . 0.0 113.435 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.1 mtt -132.42 -127.78 0.18 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.882 -1.136 . . . . 0.0 110.548 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -161.96 144.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 120.448 1.477 . . . . 0.0 112.529 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.69 -173.13 39.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.457 1.027 . . . . 0.0 114.765 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.21 -50.59 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 128.136 2.574 . . . . 0.0 113.886 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.81 30.7 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.203 1 C-N-CA 134.214 5.005 . . . . 0.0 115.745 -173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -61.01 -0.88 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 118.181 -2.824 . . . . 0.0 115.362 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.24 -12.06 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.022 1.329 . . . . 0.0 111.967 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -141.74 -5.65 1.03 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 22.4 63.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.389 0.995 . . . . 0.0 114.17 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -160.36 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.928 1.691 . . . . 0.0 111.752 -162.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -107.36 27.93 8.61 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -152.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 127.27 165.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 130.657 3.583 . . . . 0.0 112.218 166.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.97 2.63 0.37 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -145.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -117.74 83.62 2.03 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 119.994 -1.691 . . . . 0.0 114.326 -161.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -18.17 134.57 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.798 3.239 . . . . 0.0 117.811 172.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 135.69 147.21 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 1 C-N-CA 135.639 5.576 . . . . 0.0 107.561 -160.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.76 31.77 0.29 Allowed 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 124.445 3.43 . . . . 0.0 117.444 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt -136.52 1.91 2.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.67 1.988 . . . . 0.0 112.018 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.23 -12.76 0.26 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.37 1.868 . . . . 0.0 114.89 -160.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 C--O 1.255 1.373 0 CA-C-O 116.803 -1.57 . . . . 0.0 108.639 122.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.27 63.73 8.79 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 123.267 2.644 . . . . 0.0 115.074 -167.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 5' ' ' MET . 2.7 m -133.78 172.74 6.81 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.964 2.506 . . . . 0.0 110.243 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.27 5.01 6.41 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.961 3.108 . . . . 0.0 119.481 172.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -103.06 171.22 7.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 122.278 2.308 . . . . 0.0 112.359 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.3 140.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.358 -2.089 . . . . 0.0 114.534 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.57 -169.83 29.12 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.071 1.32 . . . . 0.0 112.878 -170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.78 -43.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.372 3.069 . . . . 0.0 115.9 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.6 125.08 18.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.434 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.2 m -55.64 -22.05 20.9 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -156.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -142.06 -63.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.819 1.248 . . . . 0.0 108.23 156.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.5 m -170.8 79.8 0.08 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.029 2.532 . . . . 0.0 107.806 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.59 -46.4 6.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 164.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -143.02 -93.93 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.807 2.443 . . . . 0.0 108.828 158.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -176.49 81.09 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.027 1.731 . . . . 0.0 109.985 -142.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 86.81 77.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.618 2.367 . . . . 0.0 116.367 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.23 13.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.241 2.216 . . . . 0.0 115.466 168.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.36 145.35 47.8 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 118.977 -2.327 . . . . 0.0 112.003 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -69.29 23.97 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 150.89 77.72 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.265 1.826 . . . . 0.0 110.47 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.16 -29.85 26.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.653 2.236 . . . . 0.0 113.648 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.51 175.58 13.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.856 2.062 . . . . 0.0 110.01 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.28 1.86 0.27 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 130.862 3.665 . . . . 0.0 106.029 179.379 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.726 0 N-CA-C 114.244 0.458 . . . . 0.0 114.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.64 88.58 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 CA-C-N 120.809 2.305 . . . . 0.0 114.288 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.524 HG23 ' HD2' ' A' ' 4' ' ' PRO . 2.2 m -155.13 176.9 2.25 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 127.79 2.436 . . . . 0.0 108.592 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD2' HG23 ' A' ' 3' ' ' THR . 35.7 Cg_endo -78.51 -6.72 15.6 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.492 2.795 . . . . 0.0 119.034 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.8 tpp -105.61 -178.45 3.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.824 2.102 . . . . 0.0 113.781 -165.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -122.84 135.02 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 118.709 -2.495 . . . . 0.0 114.161 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.62 -174.27 24.54 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.361 1.458 . . . . 0.0 112.965 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.14 -45.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 128.587 2.755 . . . . 0.0 115.074 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.34 118.63 4.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.084 2.154 . . . . 0.0 111.545 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.8 m -58.44 -14.18 7.15 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -150.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -140.18 -59.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.027 1.331 . . . . 0.0 108.528 152.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -178.22 87.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.973 3.309 . . . . 0.0 106.915 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.92 -43.29 5.43 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -142.58 -100.12 0.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.791 2.036 . . . . 0.0 109.499 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -165.2 88.46 0.45 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.485 2.714 . . . . 0.0 110.633 -155.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 80.89 110.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.229 2.212 . . . . 0.0 113.846 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.91 11.33 39.81 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.495 1.918 . . . . 0.0 113.326 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.52 158.88 25.69 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 119.682 -1.886 . . . . 0.0 113.103 -168.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.54 16.42 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 173.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.76 148.91 62.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.501 1.921 . . . . 0.0 109.95 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.26 -1.17 10.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.107 3.205 . . . . 0.0 115.275 -171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -172.11 -157.14 0.11 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 129.197 2.999 . . . . 0.0 108.856 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.27 -72.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.202 1.001 . . . . 0.0 108.694 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 128.791 2.837 . . . . 0.0 111.725 152.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.85 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -110.46 56.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.505 1 C-N-CA 125.317 4.011 . . . . 0.0 114.933 -165.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.435 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 1.6 p -126.88 175.07 3.57 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 119.995 -1.691 . . . . 0.0 112.373 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 3' ' ' THR . 41.6 Cg_endo -82.71 28.34 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.069 2.512 . . . . 0.0 113.4 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.3 mtt -125.68 -167.59 1.72 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.73 1.612 . . . . 0.0 110.115 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.25 147.71 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 119.917 -1.739 . . . . 0.0 113.471 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.33 -175.51 52.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.867 0.746 . . . . 0.0 113.083 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.25 -43.52 0.52 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.777 2.431 . . . . 0.0 113.905 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.47 110.58 0.14 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.969 2.508 . . . . 0.0 116.186 -158.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 t -61.75 1.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.26 2.624 . . . . 0.0 115.289 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.54 -41.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.23 1.412 . . . . 0.0 111.397 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -148.53 11.41 0.88 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 -52.44 2.93 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.111 -1.618 . . . . 0.0 113.322 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 35.85 -148.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 129.847 3.259 . . . . 0.0 117.919 145.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -101.74 44.16 1.03 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.14 1.776 . . . . 0.0 112.617 -174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 61.37 168.54 0.1 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.066 1.746 . . . . 0.0 115.391 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -125.7 -24.3 3.87 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.91 53.49 2.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -131.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . 0.317 0.1 OUTLIER 37.33 61.43 0.95 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.91 2.884 . . . . 0.0 116.056 159.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.58 170.08 11.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 116.775 -1.584 . . . . 0.0 108.054 144.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.77 47.6 1.23 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 124.121 3.214 . . . . 0.0 114.364 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.04 9.69 3.54 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 131.695 3.998 . . . . 0.0 109.306 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -173.38 9.88 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 130.185 3.394 . . . . 0.0 112.066 -160.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t0 . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 131.098 3.759 . . . . 0.0 108.164 -170.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.447 0 N-CA-C 114.309 0.484 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.13 67.19 8.2 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 CA-C-N 121.049 2.424 . . . . 0.0 114.299 -170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -143.67 179.56 1.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 126.987 2.115 . . . . 0.0 109.931 177.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 72.8 Cg_endo -93.26 -6.59 2.69 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.759 2.561 . . . . 0.0 118.759 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -87.27 160.09 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 122.044 2.202 . . . . 0.0 113.372 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.64 137.9 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 119.714 -1.867 . . . . 0.0 113.281 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.04 -174.47 25.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.646 1.117 . . . . 0.0 112.565 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -42.27 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.176 2.991 . . . . 0.0 116.402 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.27 119.35 6.74 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.093 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 t -43.94 -32.79 1.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.584 2.439 . . . . 0.0 117.584 -154.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.79 -59.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.266 1.426 . . . . 0.0 108.135 161.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 m -175.95 92.51 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.532 2.733 . . . . 0.0 108.632 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.07 -45.15 3.93 Favored Glycine 0 N--CA 1.471 0.979 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -145.64 -90.92 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.186 2.594 . . . . 0.0 107.738 161.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -172.3 99.5 0.16 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.385 2.274 . . . . 0.0 111.337 -152.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' THR . 40.9 t-105 66.95 79.24 0.24 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.33 5.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 127.999 2.52 . . . . 0.0 115.543 167.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.47 148.53 35.32 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 119.03 -2.294 . . . . 0.0 112.887 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 23.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.98 146.33 61.27 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 120.342 1.428 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.59 -31.11 13.96 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.706 2.271 . . . . 0.0 113.151 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.61 172.34 13.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.608 1.963 . . . . 0.0 109.055 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.77 -0.13 0.54 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.571 1.548 . . . . 0.0 113.556 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.751 4.42 . . . . 0.0 105.342 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.93 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -99.31 -4.7 0.67 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.801 3.667 . . . . 0.0 116.227 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 p -70.74 171.6 7.92 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 126.73 2.012 . . . . 0.0 112.796 -165.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.81 30.02 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.842 2.361 . . . . 0.0 114.905 -172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.3 mtt -131.66 -159.52 0.97 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.61 150.42 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 120.028 -1.67 . . . . 0.0 112.525 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.1 54.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.427 1.013 . . . . 0.0 112.278 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 69.24 -56.96 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.185 2.194 . . . . 0.0 113.396 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -26.88 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.678 3.191 . . . . 0.0 115.789 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.1 m -59.08 -4.53 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.394 1.878 . . . . 0.0 115.631 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.08 -30.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.692 1.597 . . . . 0.0 112.187 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -156.15 10.82 0.27 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.44 -55.4 4.65 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.268 -1.52 . . . . 0.0 112.403 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 35.62 -150.6 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 129.703 3.201 . . . . 0.0 118.279 149.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -105.8 60.74 0.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.96 1.704 . . . . 0.0 111.931 -172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.423 ' HE1' ' HB1' ' A' ' 23' ' ' ALA . 72.0 t-105 61.82 168.47 0.11 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 165.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.22 -4.72 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.566 -146.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 42.24 2.92 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.725 -1.234 . . . . 0.0 114.257 -139.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 46.3 77.49 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.84 2.856 . . . . 0.0 115.873 150.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.94 160.26 9.59 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 127.949 2.5 . . . . 0.0 108.043 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.97 18.52 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 123.275 2.65 . . . . 0.0 116.756 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -136.65 19.96 3.09 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 129.21 3.004 . . . . 0.0 111.229 167.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' HB1' ' HE1' ' A' ' 16' ' ' TRP . . . -158.97 23.28 0.21 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 128.666 2.786 . . . . 0.0 111.476 -163.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 19' ' ' HIS . 60.9 m-20 . . . . . 0 C--O 1.259 1.57 0 C-N-CA 130.004 3.322 . . . . 0.0 108.711 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.4 88.77 1.37 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.614 2.876 . . . . 0.0 115.091 -162.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 4' ' ' PRO . 4.5 m -158.57 -178.77 0.96 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 129.919 3.288 . . . . 0.0 106.804 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 3' ' ' THR . 46.8 Cg_endo -99.44 5.43 0.92 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.736 2.29 . . . . 0.0 116.387 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.408 ' H ' HG22 ' A' ' 3' ' ' THR . 1.4 mpp? -81.25 164.58 22.15 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.094 1.315 . . . . 0.0 111.182 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.67 118.6 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.642 -1.911 . . . . 0.0 112.625 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.12 -158.45 14.42 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.358 0.98 . . . . 0.0 113.768 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.15 -61.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.965 2.506 . . . . 0.0 114.1 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -43.51 -56.11 3.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.052 1.341 . . . . 0.0 114.475 -156.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m 59.05 -22.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.062 2.545 . . . . 0.0 117.476 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.95 -47.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.795 1.638 . . . . 0.0 111.686 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -65.78 2.98 0.86 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.997 2.119 . . . . 0.0 113.421 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -14.43 89.86 0.01 OUTLIER Glycine 0 N--CA 1.469 0.853 1 C-N-CA 132.304 4.764 . . . . 0.0 117.917 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -86.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 109.522 172.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -158.72 63.09 0.42 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 128.501 2.721 . . . . 0.0 110.709 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 96.07 131.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 129.291 3.036 . . . . 0.0 116.369 163.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.27 -7.25 15.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.247 1.419 . . . . 0.0 113.919 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.13 146.36 55.08 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.694 -1.879 . . . . 0.0 112.353 -165.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 44.53 0.1 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.46 147.75 26.39 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.583 1.953 . . . . 0.0 109.775 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.14 -20.58 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.666 2.244 . . . . 0.0 113.831 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 pp -144.59 170.02 16.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.418 2.287 . . . . 0.0 109.096 165.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.86 -0.8 0.51 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 C--O 1.248 1.011 1 C-N-CA 132.201 4.2 . . . . 0.0 105.465 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.72 0 N-CA-C 122.254 3.662 . . . . 0.0 122.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 83.12 2.01 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.91 3.073 . . . . 0.0 114.058 -165.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -140.65 -177.74 0.72 Allowed Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 125.283 1.433 . . . . 0.0 109.949 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.01 14.71 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.419 2.746 . . . . 0.0 117.912 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -99.36 -172.86 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 121.475 1.943 . . . . 0.0 111.712 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 p -134.75 138.28 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 118.818 -2.426 . . . . 0.0 112.837 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.82 -164.3 12.57 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.638 1.113 . . . . 0.0 112.627 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.8 -60.78 0.08 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.301 2.64 . . . . 0.0 116.005 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -39.19 -57.71 1.29 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.431 1.493 . . . . 0.0 114.013 -161.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m 59.03 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.445 2.298 . . . . 0.0 116.382 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.29 -59.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 128.917 2.887 . . . . 0.0 109.285 -169.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.2 t -75.94 11.75 1.33 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 13.17 73.04 0.01 OUTLIER Glycine 0 N--CA 1.475 1.255 0 C-N-CA 129.963 3.649 . . . . 0.0 118.163 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.77 -97.08 0.17 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 110.041 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -158.24 56.1 0.46 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.709 2.004 . . . . 0.0 112.223 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.439 ' HB3' HG22 ' A' ' 3' ' ' THR . 58.8 t-105 99.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 129.939 3.296 . . . . 0.0 116.11 164.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.78 -8.43 59.69 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 127.141 2.176 . . . . 0.0 116.264 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 148.71 47.07 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 119.336 -2.102 . . . . 0.0 113.112 -162.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 28.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.686 2.794 . . . . 0.0 118.042 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.32 149.7 71.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.267 1.827 . . . . 0.0 109.966 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.89 -22.03 27.42 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.25 1.966 . . . . 0.0 113.895 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 176.17 13.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.742 2.417 . . . . 0.0 109.344 169.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.3 1.26 0.32 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.746 3.619 . . . . 0.0 106.222 177.595 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.11 76.07 4.55 Favored 'Trans proline' 0 CA--C 1.55 1.315 0 CA-C-N 121.546 2.673 . . . . 0.0 116.591 -159.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.252 0.6 OUTLIER -144.49 -164.01 0.07 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 116.03 -1.938 . . . . 0.0 108.335 155.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.15 -0.6 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.478 0 CA-C-N 125.076 2.848 . . . . 0.0 117.1 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -77.19 158.86 30.11 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.902 1.683 . . . . 0.0 112.854 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.269 10.2 p -96.75 83.06 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 119.738 -1.851 . . . . 0.0 114.26 -166.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.61 -137.21 6.11 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.021 -1.05 . . . . 0.0 114.988 166.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 -58.37 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 129.516 3.127 . . . . 0.0 115.993 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -49.28 -39.84 32.34 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -147.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m 61.97 -30.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.984 2.913 . . . . 0.0 117.71 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 t -136.1 -36.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.704 2.402 . . . . 0.0 110.027 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 t -74.31 11.71 0.91 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.722 2.009 . . . . 0.0 114.368 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.05 96.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 129.675 3.512 . . . . 0.0 118.944 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.16 -90.13 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.713 1.605 . . . . 0.0 108.72 167.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -153.11 74.06 1.02 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 128.452 2.701 . . . . 0.0 111.077 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 81.07 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 118.842 2.905 . . . . 0.0 118.842 157.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.99 6.07 0.57 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 117.875 -3.015 . . . . 0.0 115.781 174.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 132.85 55.24 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 119.357 -2.09 . . . . 0.0 111.182 -170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.17 37.05 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 -168.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.55 155.59 66.94 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.709 2.004 . . . . 0.0 110.249 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 -15.6 25.83 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.449 2.1 . . . . 0.0 113.928 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.2 177.7 8.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.992 2.517 . . . . 0.0 108.731 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -144.41 -42.75 0.25 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.349 0.66 . . . . 0.0 111.747 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 112.107 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.818 0 N-CA-C 116.788 1.475 . . . . 0.0 116.788 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.38 65.64 8.26 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 124.257 3.304 . . . . 0.0 114.152 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -179.9 1.08 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.48 1.512 . . . . 0.0 110.281 175.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -87.66 -7.56 6.46 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 N-CA-C 119.036 2.668 . . . . 0.0 119.036 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -90.86 164.33 14.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 121.852 2.115 . . . . 0.0 113.263 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.85 141.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 120.017 -1.677 . . . . 0.0 112.712 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.09 -174.31 23.09 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.539 1.066 . . . . 0.0 112.784 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.52 -55.49 0.27 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.518 2.727 . . . . 0.0 115.299 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.38 -44.63 54.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.303 2.241 . . . . 0.0 115.14 -156.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m 51.21 -11.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 130.302 3.441 . . . . 0.0 119.712 164.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 t -141.16 -53.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.441 1.896 . . . . 0.0 110.278 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -70.0 -15.41 63.02 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.27 42.95 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.366 1.46 . . . . 0.0 116.256 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.55 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -146.86 -173.39 4.21 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 119.368 1.584 . . . . 0.0 112.611 -156.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.55 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.3 m-85 -74.32 88.46 2.04 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 128.002 2.521 . . . . 0.0 115.547 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 63.93 92.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 163.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.64 6.13 3.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.882 2.073 . . . . 0.0 116.524 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 149.94 46.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 118.899 -2.376 . . . . 0.0 112.909 -170.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 27.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.73 152.15 78.33 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.62 1.568 . . . . 0.0 110.437 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.84 -28.02 20.6 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.401 2.067 . . . . 0.0 112.983 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.37 173.79 13.61 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.875 2.07 . . . . 0.0 110.212 168.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.03 -1.72 0.35 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.179 1.391 . . . . 0.0 113.867 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.26 1.637 1 C-N-CA 132.253 4.221 . . . . 0.0 105.275 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.178 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.2 78.28 3.74 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 125.042 3.828 . . . . 0.0 113.793 -170.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 5' ' ' MET . 3.4 m -150.57 175.82 2.63 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.678 1.991 . . . . 0.0 109.199 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -89.07 -11.62 3.63 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 118.638 2.514 . . . . 0.0 118.638 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.43 ' H ' HG22 ' A' ' 3' ' ' THR . 2.4 mpp? -82.16 171.8 13.9 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.054 1.752 . . . . 0.0 112.943 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.35 138.11 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.056 -1.653 . . . . 0.0 113.2 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.71 -170.0 20.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.409 1.004 . . . . 0.0 112.248 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -67.61 0.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.856 2.462 . . . . 0.0 114.249 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -37.63 -61.6 0.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 129.766 3.226 . . . . 0.0 114.722 -163.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m 58.09 -10.92 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.9 -48.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.535 1.534 . . . . 0.0 111.111 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.4 t -75.38 -5.5 45.19 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.35 76.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.924 1.726 . . . . 0.0 115.427 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.48 -178.28 5.55 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 119.148 1.474 . . . . 0.0 112.8 -156.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.484 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 68.2 m-85 -72.12 83.2 0.99 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.168 2.187 . . . . 0.0 114.8 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 72.83 153.66 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.521 2.328 . . . . 0.0 116.585 166.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.7 5.68 0.25 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 113.69 -161.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 153.66 35.91 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.621 -1.925 . . . . 0.0 111.215 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 30.17 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.4 149.89 70.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.425 1.89 . . . . 0.0 110.192 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.47 -22.13 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.263 2.642 . . . . 0.0 113.493 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.13 172.83 15.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.0 110.264 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.78 -22.1 0.72 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.793 1.637 . . . . 0.0 112.457 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 130.526 3.531 . . . . 0.0 108.696 171.029 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.762 0 N-CA-C 122.41 3.724 . . . . 0.0 122.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.98 84.64 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.227 3.284 . . . . 0.0 114.593 -166.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.28 -175.29 0.46 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.351 1.46 . . . . 0.0 110.052 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -86.84 8.74 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.669 0 C-N-CA 122.958 2.439 . . . . 0.0 118.249 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.78 176.03 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 121.694 2.043 . . . . 0.0 112.239 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.69 135.64 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 119.204 -2.185 . . . . 0.0 113.789 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.7 -162.07 12.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.426 1.013 . . . . 0.0 113.245 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.06 -59.11 0.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 129.306 3.043 . . . . 0.0 116.433 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -41.16 -53.01 3.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.743 1.617 . . . . 0.0 113.963 -162.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m 58.81 -15.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.863 2.465 . . . . 0.0 117.08 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.97 -55.55 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 129.778 3.231 . . . . 0.0 108.135 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -72.43 4.63 3.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.044 2.138 . . . . 0.0 115.271 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 24.94 62.73 0.05 OUTLIER Glycine 0 CA--C 1.538 1.53 0 C-N-CA 129.474 3.416 . . . . 0.0 119.118 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 -99.26 0.16 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.89 1.345 . . . . 0.0 111.231 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -158.25 68.24 0.48 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 127.322 2.249 . . . . 0.0 111.103 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 84.33 105.14 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 128.274 2.63 . . . . 0.0 117.574 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -8.73 59.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 127.423 2.289 . . . . 0.0 116.14 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 149.81 46.69 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.688 -1.882 . . . . 0.0 112.751 -159.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 27.49 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.3 148.96 71.1 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.435 1.894 . . . . 0.0 109.85 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 -24.5 31.88 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.373 2.049 . . . . 0.0 113.707 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.27 175.33 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.428 2.291 . . . . 0.0 109.385 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -151.91 -2.66 0.29 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 130.889 3.676 . . . . 0.0 106.583 -178.279 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -84.16 79.35 2.64 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.628 2.219 . . . . 0.0 115.182 -161.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.46 -174.43 0.41 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.037 1.335 . . . . 0.0 111.114 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.91 -2.2 7.24 Favored 'Trans proline' 0 CA--C 1.554 1.496 0 N-CA-C 119.435 2.821 . . . . 0.0 119.435 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -95.76 174.43 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 122.171 2.26 . . . . 0.0 112.775 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.62 132.39 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 119.62 -1.925 . . . . 0.0 113.418 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.97 -172.09 14.43 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.545 1.545 . . . . 0.0 112.075 -173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.22 -57.72 0.29 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.236 2.614 . . . . 0.0 115.472 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -58.73 3.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 128.042 2.537 . . . . 0.0 115.238 -163.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 57.96 -9.78 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 166.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.3 t -139.57 -53.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.769 2.028 . . . . 0.0 111.093 -168.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -76.07 -13.05 60.22 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.466 1.03 . . . . 0.0 113.216 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.97 58.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.097 1.332 . . . . 0.0 114.853 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 179.13 6.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.849 1.324 . . . . 0.0 113.456 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -73.79 85.89 1.69 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.226 2.21 . . . . 0.0 115.768 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 70.79 120.13 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 162.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.87 14.87 16.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.783 1.633 . . . . 0.0 113.476 -162.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.52 138.87 58.65 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.403 -2.061 . . . . 0.0 110.956 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -51.36 31.22 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 128.812 2.845 . . . . 0.0 117.515 159.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.64 153.77 65.46 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 128.141 2.576 . . . . 0.0 109.709 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.3 -23.14 24.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.067 1.845 . . . . 0.0 114.212 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 pp -154.41 -178.34 7.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.267 1.827 . . . . 0.0 110.808 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.56 -2.83 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.26 1.633 0 C-N-CA 131.13 3.772 . . . . 0.0 105.708 178.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.98 51.3 3.38 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 124.598 3.532 . . . . 0.0 114.017 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 15' ' ' TYR . 6.7 m -135.14 172.12 7.78 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 128.769 2.828 . . . . 0.0 108.166 -172.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 3' ' ' THR . 97.6 Cg_endo -96.27 -15.13 0.44 Allowed 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 118.417 2.43 . . . . 0.0 118.417 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -79.95 164.92 23.13 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 121.202 1.819 . . . . 0.0 113.353 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.09 138.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 119.7 -1.875 . . . . 0.0 113.476 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 -165.97 22.17 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.813 1.197 . . . . 0.0 113.314 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -50.71 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.903 3.281 . . . . 0.0 116.763 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.77 113.07 0.76 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.44 1.896 . . . . 0.0 109.342 169.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -64.46 -7.55 10.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -144.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.35 -62.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.934 1.694 . . . . 0.0 107.47 153.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 p -179.37 91.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.035 2.534 . . . . 0.0 109.072 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 -48.56 5.27 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 162.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.41 -90.63 0.19 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.924 2.09 . . . . 0.0 108.107 156.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' A' ' 3' ' ' THR . 2.6 m-85 -167.48 106.57 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.753 1.621 . . . . 0.0 111.065 -150.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 62.61 77.45 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.509 2.324 . . . . 0.0 116.687 168.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.89 22.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 127.559 2.344 . . . . 0.0 115.152 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -73.6 140.42 46.2 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 118.616 -2.552 . . . . 0.0 111.906 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -68.98 29.13 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 115.176 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.79 151.8 63.95 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.903 2.081 . . . . 0.0 110.282 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -27.65 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.751 2.3 . . . . 0.0 114.273 -171.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.07 -177.32 5.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.294 2.638 . . . . 0.0 109.015 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.47 -59.34 0.27 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.418 1.487 . . . . 0.0 109.15 170.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.752 2.421 . . . . 0.0 111.909 157.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.52 57.62 6.48 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.894 3.062 . . . . 0.0 114.087 -175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 179.39 1.37 Allowed Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 125.161 1.384 . . . . 0.0 110.662 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -86.92 -9.88 6.18 Favored 'Trans proline' 0 CA--C 1.552 1.405 0 N-CA-C 118.773 2.566 . . . . 0.0 118.773 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -88.43 167.42 13.49 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.615 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.79 129.7 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 119.88 -1.763 . . . . 0.0 112.818 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.88 -166.37 12.28 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.867 1.222 . . . . 0.0 112.054 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.42 -63.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.329 2.652 . . . . 0.0 115.961 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -37.68 -58.91 0.85 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.076 3.351 . . . . 0.0 114.359 -166.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.8 t 53.19 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.338 3.055 . . . . 0.0 118.902 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.98 -50.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.682 1.593 . . . . 0.0 110.136 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -66.73 -14.09 62.14 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.75 11.48 57.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.508 2.004 . . . . 0.0 115.769 164.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.37 -168.68 2.88 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 118.906 1.353 . . . . 0.0 112.001 -157.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 61.8 m-85 -79.28 88.78 4.92 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 126.913 2.085 . . . . 0.0 114.321 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 67.86 99.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 159.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.37 9.86 2.92 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.38 133.83 56.48 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 118.22 -2.8 . . . . 0.0 112.32 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -49.79 17.92 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 130.045 3.338 . . . . 0.0 117.91 165.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.56 153.95 79.35 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 128.142 2.577 . . . . 0.0 109.148 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.3 -19.61 33.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.082 1.855 . . . . 0.0 114.217 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.66 -176.13 5.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.51 1.924 . . . . 0.0 110.976 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.21 -70.99 0.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.422 1.089 . . . . 0.0 109.69 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.143 0 O-C-N 124.877 1.361 . . . . 0.0 110.31 141.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.803 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.14 57.68 6.61 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.277 3.318 . . . . 0.0 112.867 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 166.36 26.1 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.947 1.699 . . . . 0.0 110.77 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.53 -4.74 10.08 Favored 'Trans proline' 0 CA--C 1.551 1.358 0 N-CA-C 118.68 2.531 . . . . 0.0 118.68 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -95.89 157.61 15.82 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 121.537 1.971 . . . . 0.0 112.249 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.77 145.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.28 -1.513 . . . . 0.0 113.085 -174.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.32 -172.12 23.91 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.684 1.135 . . . . 0.0 112.87 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.95 -35.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.704 3.202 . . . . 0.0 117.62 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.08 37.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 130.641 3.577 . . . . 0.0 115.086 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 m -60.79 0.28 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.628 3.971 . . . . 0.0 116.065 -163.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.04 -50.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.371 1.868 . . . . 0.0 109.739 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -64.41 -16.89 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.843 1.257 . . . . 0.0 113.978 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.44 16.22 53.38 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 158.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -109.87 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.833 1.253 . . . . 0.0 111.42 -156.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -145.56 99.66 3.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -162.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 50.93 77.3 0.13 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.592 2.757 . . . . 0.0 117.061 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.4 4.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.452 2.301 . . . . 0.0 115.304 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 144.59 44.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.248 -2.157 . . . . 0.0 111.608 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.19 28.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.04 151.37 78.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.275 1.43 . . . . 0.0 110.831 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -28.45 23.18 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.518 2.145 . . . . 0.0 112.993 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.26 173.55 14.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.333 2.253 . . . . 0.0 110.15 170.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.64 -1.81 0.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.206 1.402 . . . . 0.0 114.024 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.261 1.676 1 C-N-CA 132.232 4.213 . . . . 0.0 105.515 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.119 0 N-CA-C 121.853 3.501 . . . . 0.0 121.853 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 95.74 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.523 2.815 . . . . 0.0 114.172 -170.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 4' ' ' PRO . 3.2 m -149.61 173.58 4.15 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.625 2.37 . . . . 0.0 108.42 171.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 3' ' ' THR . 57.7 Cg_endo -78.97 12.07 2.37 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 124.055 3.17 . . . . 0.0 117.396 169.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 tpp -118.1 -178.14 3.44 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 121.475 1.943 . . . . 0.0 112.215 -166.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.04 136.8 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 118.555 -2.59 . . . . 0.0 113.532 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.31 -167.02 12.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.476 1.512 . . . . 0.0 112.593 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.23 -65.59 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.552 2.341 . . . . 0.0 115.323 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -35.81 -59.98 0.55 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.78 1.632 . . . . 0.0 113.926 -157.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m 59.39 -18.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.617 2.367 . . . . 0.0 116.41 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.63 -60.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.488 2.315 . . . . 0.0 108.943 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -76.61 27.78 0.13 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -28.71 93.35 0.01 OUTLIER Glycine 0 N--CA 1.474 1.175 0 C-N-CA 129.31 3.338 . . . . 0.0 117.004 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.8 -88.79 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.396 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -155.54 56.81 0.63 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 127.224 2.209 . . . . 0.0 113.058 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 98.71 129.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 130.85 3.66 . . . . 0.0 115.471 165.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -3.96 24.3 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.973 1.709 . . . . 0.0 115.002 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 158.8 34.94 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 119.74 -1.85 . . . . 0.0 113.388 -161.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 23.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.78 150.31 65.18 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.162 1.785 . . . . 0.0 109.696 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.48 -9.82 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.283 2.655 . . . . 0.0 114.808 -171.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -160.06 -171.54 3.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.126 2.97 . . . . 0.0 108.38 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.35 -4.61 0.6 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--O 1.249 1.056 1 C-N-CA 131.872 4.069 . . . . 0.0 104.784 166.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 122.601 3.801 . . . . 0.0 122.601 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HA ' HE21 ' A' ' 14' ' ' GLN . 63.1 Cg_endo -85.04 80.84 2.02 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.648 2.899 . . . . 0.0 115.068 -165.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.89 -173.55 0.37 Allowed Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.101 1.36 . . . . 0.0 110.547 171.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.28 9.02 3.07 Favored 'Trans proline' 0 CA--C 1.555 1.564 0 N-CA-C 118.016 2.275 . . . . 0.0 118.016 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.19 165.78 11.54 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 121.396 1.907 . . . . 0.0 111.918 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -112.31 131.17 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 119.128 -2.232 . . . . 0.0 113.573 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.7 -158.57 14.4 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.813 1.197 . . . . 0.0 112.606 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.55 -60.92 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.397 3.079 . . . . 0.0 116.702 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -38.61 -57.68 1.14 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.005 1.722 . . . . 0.0 114.066 -161.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m 59.23 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.098 2.159 . . . . 0.0 116.584 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.43 -58.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 128.393 2.677 . . . . 0.0 109.208 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -72.97 10.15 0.98 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 5.61 75.82 0.01 OUTLIER Glycine 0 N--CA 1.475 1.24 1 C-N-CA 130.808 4.051 . . . . 0.0 118.212 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -140.96 -91.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.116 1.366 . . . . 0.0 109.541 177.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -158.88 79.04 0.77 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 127.779 2.431 . . . . 0.0 111.394 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 77.57 96.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 161.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.92 2.6 3.31 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 129.193 2.997 . . . . 0.0 117.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -67.13 142.69 56.99 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 118.789 -2.444 . . . . 0.0 112.955 -168.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -67.81 28.44 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.17 151.8 79.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.864 2.066 . . . . 0.0 109.898 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.88 -25.85 27.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 113.478 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 pp -154.5 176.02 12.88 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.157 2.183 . . . . 0.0 110.27 172.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.89 -3.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.904 1.282 . . . . 0.0 114.247 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 C-N-CA 131.365 3.866 . . . . 0.0 106.296 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.07 84.59 1.53 Allowed 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.638 2.892 . . . . 0.0 114.105 -167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.21 178.62 1.39 Allowed Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.523 1.129 . . . . 0.0 110.93 169.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.81 12.8 1.59 Allowed 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 123.973 3.116 . . . . 0.0 119.18 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.59 -166.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.986 2.176 . . . . 0.0 111.818 -173.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.28 141.76 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 118.526 -2.609 . . . . 0.0 112.727 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -159.6 13.93 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.865 1.221 . . . . 0.0 112.496 -173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.1 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.639 3.575 . . . . 0.0 118.421 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 40.6 m-20 -42.28 -65.15 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.438 1.495 . . . . 0.0 113.648 -170.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.99 -4.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.511 2.724 . . . . 0.0 117.953 176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.65 -52.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 130.261 3.424 . . . . 0.0 108.67 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 t -78.33 -42.34 30.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.43 1.492 . . . . 0.0 113.154 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . 75.86 68.08 1.6 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.551 1.548 . . . . 0.0 114.726 171.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 -95.41 0.13 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.189 0.995 . . . . 0.0 110.801 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -159.28 58.99 0.4 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 127.12 2.168 . . . . 0.0 112.847 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 99.73 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 129.394 3.078 . . . . 0.0 116.152 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.8 0.38 39.55 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.969 2.108 . . . . 0.0 115.422 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.99 147.84 51.1 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 119.297 -2.127 . . . . 0.0 112.938 -166.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -68.48 25.14 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.775 1.63 . . . . 0.0 115.262 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.66 151.33 77.87 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.149 2.18 . . . . 0.0 110.664 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.68 -26.53 19.41 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.707 2.271 . . . . 0.0 113.355 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp -158.85 173.47 16.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.139 2.175 . . . . 0.0 109.773 170.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -152.21 -1.63 0.28 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 130.273 3.429 . . . . 0.0 106.329 177.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.948 0 N-CA-C 113.853 0.301 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.99 75.09 4.93 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 123.515 2.81 . . . . 0.0 115.462 -160.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.78 -175.85 0.51 Allowed Pre-proline 0 N--CA 1.487 1.396 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.092 166.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -90.35 -12.15 2.74 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 N-CA-C 118.624 2.509 . . . . 0.0 118.624 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.81 168.52 16.07 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 121.177 1.808 . . . . 0.0 112.869 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.55 135.55 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 119.559 -1.963 . . . . 0.0 113.158 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.5 -165.35 12.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.03 1.3 . . . . 0.0 113.135 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.49 -64.23 0.1 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.024 2.929 . . . . 0.0 115.603 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -40.07 -57.47 1.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.155 3.382 . . . . 0.0 114.567 -161.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m 57.2 -11.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 170.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.86 -51.11 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.954 1.702 . . . . 0.0 111.181 -166.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 t -78.03 -1.89 34.46 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 21.19 79.88 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.391 1.948 . . . . 0.0 115.406 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -137.55 -179.78 5.95 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.629 1.215 . . . . 0.0 112.917 -161.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.546 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 59.9 m-85 -74.47 84.92 2.01 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 127.536 2.335 . . . . 0.0 114.999 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 72.8 88.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 158.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.63 1.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.86 141.95 58.45 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.823 -2.423 . . . . 0.0 112.857 -167.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -67.13 29.11 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.2 151.39 76.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.095 2.558 . . . . 0.0 109.246 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.55 -26.4 23.92 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.093 1.862 . . . . 0.0 113.503 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -151.71 173.22 14.96 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.468 1.907 . . . . 0.0 110.164 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.67 -2.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.194 1.398 . . . . 0.0 114.007 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.249 1.043 1 C-N-CA 131.885 4.074 . . . . 0.0 105.207 -178.34 . . . . . . . . 1 1 . 1 stop_ save_